Function and role of microparticles in various clinical settings. - sprookjes - yvandenbroek - TriplyDB

Function and role of microparticles in various clinical settings.

Function and role of microparticles in various clinical settings.

http://www.wikidata.org/entity/Q33380547

about

Disturbances of apoptotic cell clearance in systemic lupus erythematosus Microparticles as Biomarkers of Blood Coagulation in Cancer Clinical significance of procoagulant microparticles Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancer Isolation and characterization of microparticles in sputum from cystic fibrosis patients Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis.Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems.Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity.Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia.Antibacterial effect of microvesicles released from human neutrophilic granulocytes.Microparticles as novel biomarkers and therapeutic targets in coronary heart disease.Human lung cancer-derived microparticles enhanced angiogenesis and growth of hepatoma cells in rodent lung parenchyma Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction Levels of circulating microparticles in lung cancer patients and possible prognostic value.Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.Circulating microparticles enhanced rat vascular wall remodeling following endothelial denudation.Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease.The role of microparticles in chronic obstructive pulmonary disease Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.Antiplatelet antibody may cause delayed transfusion-related acute lung injury.Platelets and their microparticles as key players in pathophysiological responses.Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.Extracellular vesicles and blood diseases.The Endothelium as a Target in Pediatric OSA.Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells.Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis.Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release.New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer.Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism.Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus.The predictive role of circulating microparticles in patients with chronic heart failure.Time course of plasma microparticle concentrations after acute spontaneous basal ganglia hemorrhage.

P2860

Q21195358-399AFCD4-6128-4E18-B1BA-8BA7AC0958DE Q26783691-F0204EA3-7F86-465B-BC6B-EF68FF3F7D39 Q26830846-4BA8AC86-C214-4D4B-92A2-9C2B2E01F7D2 Q33720417-69C42BC8-8EB1-48C6-B5CF-86DE3CEC5914 Q33908558-3878AFA6-D07F-45E2-ADB7-AAC55F78BFFE Q34020055-18106910-1FD2-4B36-A18C-58295A758AD0 Q34488533-F26BD7B7-1C43-4626-80D4-2004BC6CC0C4 Q34560286-43403764-3242-487B-AEF2-6D3E35E1BE9A Q35041174-0CDFBDF1-BB7A-44F5-B952-8C3329B4BDC9 Q35204306-F86DC287-3249-471D-BC34-F268FA41C771 Q35848911-B1BE07CC-4A00-4D6D-A118-A9D9D3AEF34B Q36236572-7A0B6C0E-4AA6-429B-8DAB-B90C20453733 Q36283002-E8A8FE76-4CBD-4C20-A816-687F6F235479 Q36331121-1F9F85C6-7A92-4AD7-92E3-12F3ED9E843D Q36542831-D0788284-9F24-42BC-AD60-56722E20EBB5 Q36816361-11436186-628D-4639-A980-03B5F4D7F83B Q36878519-022DB839-F3B9-4965-AFE8-5F30F79FE1B6 Q36958267-F6FD98B8-0A0D-4691-ABF6-E1593314ADDE Q37208677-E173D4AD-9929-4E57-BC5C-A7B1E354D431 Q37234102-7CEAC2B8-777D-47BA-88FC-866A2FF59F2D Q37448030-6B32836F-5046-4AEA-BD0E-9F862539489D Q37663392-6965B990-2A32-4653-9716-57B35F0A06F3 Q38115105-A2298E42-186C-4ADE-B129-C156C9224EFF Q38202635-28C385C7-203B-4738-85B9-2A7B589E1712 Q38206278-AF1ECF45-D6CA-4EBC-8A17-5134FF20B00D Q38443364-2DB10E7F-0533-4AF6-BD20-96985783D88F Q38539151-EDAC8A53-2B9F-4C35-878C-40AED1560097 Q38543319-6EBA2AA1-11E1-4C4B-A2DF-AB060AAFF506 Q38908954-5496F51E-8496-4394-AF12-7C486B06540C Q39107240-6839DA04-62E1-4D30-B60B-5CA94F479691 Q39602294-80CA2DAF-7D37-4B77-9405-293158427E8B Q39628120-B22A3740-704A-4229-9D4A-9FE20C4F5A33 Q40294653-DD30CC09-C0AC-4BE8-B85E-EFC430D15F4C Q40582473-81B0EFC3-C087-4502-9948-345A04409EBC Q41283854-5A88ED76-0173-4FBE-9952-710869B85EC4 Q41292245-5BDB0632-5131-4101-B449-1C4D64E52C84 Q41994855-16E8B414-B220-4350-BCC9-9FB401076229 Q42121320-8743EC16-C1BC-42AF-94EC-9C96B444C08E Q42152321-BEF676AD-B700-4BD0-BA12-5D1A2F9FEF93 Q42473703-BDB098D2-276B-4637-AEEE-8AC34F9ADD4B

P2860

Function and role of microparticles in various clinical settings.

http://www.wikidata.org/entity/Q33380547

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Function and role of microparticles in various clinical settings.

@ast

Function and role of microparticles in various clinical settings.

@en

type

label

Function and role of microparticles in various clinical settings.

@ast

Function and role of microparticles in various clinical settings.

@en

prefLabel

Function and role of microparticles in various clinical settings.

@ast

Function and role of microparticles in various clinical settings.

@en

P1433

Q33380547-7C786875-8B75-484B-8C9A-41A1811BE20C

P1476

Q33380547-2DC43F1D-46BF-4459-8FF7-8467CF842273

P2093

Q33380547-1F0AF8C8-1770-4766-BF82-F9EDDF955503

Q33380547-543E843E-5C10-48B2-AD51-4DAB060EE79D

Q33380547-D8C7A36D-F0F2-456D-8B2E-7189D94DBF18

P304

Q33380547-9ED478F1-3C3A-4102-8634-BD6432D60B42

P31

Q33380547-4FF05DF4-B02F-48E3-81C5-681DA093DD23

P356

Q33380547-437476A4-7C5A-4F5E-A2C9-94234C0F2522

P433

Q33380547-4618B642-35D7-4BF6-AF2B-B5F8D16A35EA

P478

Q33380547-37C23DC7-B897-4172-92B9-FECA3CA73F16

P577

Q33380547-306B9272-903A-4C31-806E-4E770E82FF4E

P5875

Q33380547-C9B7A464-1A02-4D11-8A9B-EA05A3950279

P698

Q33380547-E8DA9404-544E-475E-AFC1-894F767B2536

P356

J.THROMRES.2008.06.006

P1433

Thrombosis Research

P1476

Function and role of microparticles in various clinical settings.

@en

P2093

Shosaku Nomura

http://www.w3.org/2001/XMLSchema#string

Yasuo Ikeda

http://www.w3.org/2001/XMLSchema#string

Yukio Ozaki

http://www.w3.org/2001/XMLSchema#string

P304

8-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.THROMRES.2008.06.006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23137635

http://www.w3.org/2001/XMLSchema#string

P698

18667228

http://www.w3.org/2001/XMLSchema#string